Implementation and One-Year Evaluation of Proenkephalin A in Critical Care
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26062602 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Lukas Martin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany. Hauptthemen laut MEDLINE: Enkephalins, Critical Care, Acute Kidney Injury, Protein Precursors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Proenkephalin A 119–159 (PENK) is a promising functional kidney biomarker, evaluated in various clinical settings. In critical care medicine, early diagnosis of acute kidney injury (AKI) is crucial; however, to date, the diagnosis and the assessment of kidney function is still based on serum creatinine (sCr) and urine output, both associated with several limitations. Between November 2020 and March 2022, we implemented PENK in our daily practice on our intensive care units (ICU). PENK, sCr, AKI stage, and the start and duration of renal replacement therapy (RRT) were documented. Almost 18,000 PENK measurements from 4169 patients were analyzed, and the glomerular filtration rate (GFR) was estimated with the new PENK-GFR formula. PENK outperformed sCR in the kidney function assessment and sCR trajectory over time. Moreover, PENK predicted the use of RRT and thus showed its usefulness in critical care daily practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Medicine, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany.
- Laboratory Diagnostic Center, University Hospital RWTH Aachen, 52074 Aachen, Germany.
- Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.
- Department of Cardiology, Angiology and Internal Intensive Care Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.
- Department of Nephrology, Rheumatology, Clinical Immunology and Hypertension, University Hospital RWTH Aachen, 52074 Aachen, Germany.
ORCID-Profile: Caren Martin, Matthias Imöhl, Alexander Kersten, Turgay Saritas, Michael Dreher
Zitieren
APA
Martin, L., Martin, C., Peine, A., Imöhl, M., Kersten, A., Kramann, R., Saritas, T., Marx, N., Dreher, M., Marx, G., & Simon, T. P. (2025). Implementation and One-Year Evaluation of Proenkephalin A in Critical Care. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062602
Vancouver
Martin L, Martin C, Peine A, Imöhl M, Kersten A, Kramann R, et al. Implementation and One-Year Evaluation of Proenkephalin A in Critical Care. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062602
BibTeX
@article{Martin2025,
author = {Martin, Lukas and Martin, Caren and Peine, Arne and Imöhl, Matthias and Kersten, Alexander and Kramann, Rafael and Saritas, Turgay and Marx, Nikolaus and Dreher, Michael and Marx, Gernot and Simon, Tim-Philipp},
title = {Implementation and One-Year Evaluation of Proenkephalin A in Critical Care},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26062602}
}
EUVIMED